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Two-dimensional electrophoresisOveroxidation and subsequent inactivation of Peroxiredoxin III (PrxIII), a mitochondrial H2O2 scavenging
enzyme, have been reported in oxidative stress conditions. No data are available in the literature about the
presence of overoxidized forms of PrxIII in aged tissues. Liver mitochondria from 12-month-old rats and 28-
month-old rats were here analyzed by two-dimensional gel electrophoresis. A spot corresponding to the
native form of PrxIII was present in adult and old rats with the same volume, whereas an additional, more
acidic spot, of the same molecular weight of the native form, accumulated only in old rats. The acidic spot
was identiﬁed, by MALDI-MS analysis, as a form of PrxIII bearing the cysteine of the catalytic site
overoxidized to sulphonic acid. This modiﬁed PrxIII form corresponds to the irreversibly inactivated enzyme,
here reported, for the ﬁrst time, in aging. Three groups of 28-month-old rats treated with acetyl-L-carnitine
were also examined. Reduced accumulation of the overoxidized PrxIII form was found in all ALCAR-treated
groups.© 2009 Elsevier B.V. All rights reserved.1. Introduction
Mitochondria play a key role in aging since they are the major
source of intracellular reactive oxygen species (ROS) and, at the same
time, the primary target of their action. Mitochondria, which utilize
90% of cellular oxygen, produce ROS as by-products of the respiration:
in physiological conditions 0.2% of the utilized oxygen is converted
into ROS [1]. ROS are highly reactive molecules harmful to the cell
macromolecules: mitochondrial macromolecules, which are nearby
the major source of ROS, are primarily damaged. ROS production
increases during aging and seems to be responsible for the oxidative
damage to mitochondrial macromolecules veriﬁed in different agingde gel electrophoresis; ALCAR,
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ll rights reserved.tissues [2]. To cope with ROS the cell expresses several antioxidant
enzymes which are localized in different cellular compartments [3].
Peroxiredoxins (Prxs) are a family of peroxidases, with ubiquitous
distribution [4]. Mammalian Prxs include six members (Prx I–VI).
Peroxiredoxin III (PrxIII) is exclusively located into mitochondria and
it is involved in the regulation of mitochondrial H2O2 concentration. It
is about 30-fold more abundant than glutathione peroxidase I in
mitochondria of HeLa cells [5]. PrxIII belongs to 2-Cys Prxs subgroup,
which contains two conserved Cys residues, both required for the
catalytic function. In the catalytic cycle of 2-Cys Prx proteins, the
conserved “peroxidatic” cysteine residue of each subunit of the Prx
homodimer is selectively oxidized by H2O2 to sulphenic acid (Cys-
SOH), which then reacts with the conserved “resolving” Cys of the
other subunit to form an intermolecular disulﬁde. In order to complete
the enzymatic catalytic cycle, the peroxiredoxin is reduced back to its
active thiol form by the thioredoxin/thioredoxin reductase system [6].
However, the formation of the disulﬁde is a slow process, thus under
oxidative stress conditions, the sulphenic intermediate can be easily
overoxidized to cysteine sulphinic (Cys-SO2H) or sulphonic acid (Cys-
SO3H), resulting in the inactivation of peroxidase activity [7]. Never-
theless, the cysteine sulphinic acid form of 2-Cys Prxs, in vitro, can be
reduced to the catalytically active thiol form by sulﬁredoxin [8],
whereas the cysteine sulphonic acid form cannot be reduced to the
active form [7].
The presence of overoxidized forms for Prx I, II, III and IV has been
reported in cell cultures treated with H2O2 [9,10] or with other
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forms of Prxs were identiﬁed after ischemia/reperfusion occurring
during human liver transplantation [10]. At the present, nothing is
known about the status of the mitochondrial PrxIII in the oxidative
stress conditions associated with aging.
The purpose of the current study was to investigate about the
presence of oxidized forms of PrxIII in aged rat liver where oxidative
stress and loss of Complex I, Complex IV, Mn SOD andmtNOS activities
have been described [12,13].
Acetyl-L-carnitine (ALCAR) is a naturally occurring substance that
has been reported to limit age-linked mitochondrial macromolecular
damages and mitochondrial function alterations in heart, brain and
skeletal muscle [14–24]. In perfused old rat livers, 1 month of ALCAR
treatment slows down the age-associated decline of mitochondrial
respiration and biosynthetic functions [25]. Furthermore, in hepato-
cytes of old rats, ALCAR supplementation in drinking water for
1 month reversed the age-associated decline of mitochondrial
membrane potential; additionally it restored the cardiolipin content,
which declined signiﬁcantly with age, and raised cellular oxygen
consumption to the level of young rats [26]. In several oxidative stress
conditions a protective role of ALCAR was reported, mainly in the
brain, on generalized proteins oxidation [27–32]. By using a redox
proteomic approach, the protective effect of ALCAR treatment on the
increased carbonylation of speciﬁc proteins in the brain was reported
by Poon et al. [33].
Results reported here show that, as revealed by two-dimensional
gel electrophoresis, an acidic form of PrxIII was present and
accumulated in old rats whereas the native form of PrxIII was present,
at the same level, both in adult and in old animals. Mass spectrometry
analysis showed that the acidic form of PrxIII was the form with the
cysteine of the catalytic site overoxidized to cysteine sulphonic acid.
ALCAR treatment of old rats reduced the content of this overoxidized
form of PrxIII in liver mitochondria.
2. Materials and methods
2.1. Animals
Male Fisher-344 Charles–River rats were maintained on a 12:12 h
light–dark cycle at 25 °C and had access to standard laboratory chow
and water ad libitum. All procedures were in accordance with the
Italian Ministry of Health Guidelines (no. 86/609/EEC). Experiments
were performed on ﬁve groups of rats belonged to the following
groups: 12-month-old rats (adult group, n=4), 28-month-old rats
(old group, n=4), 28-month-old rats treated with ALCAR for
1 month (n=4), 28-month-old rats treated with ALCAR for 2 months
(n=4), 28-month-old rats treated with ALCAR for 2 months and
analyzed after 1 month of treatment suspension (n=4). Treated rats
were allowed to drink ad libitum a 1.5% (w/v, pH adjusted to 6.5)
solution of ALCAR. No difference in food and water assumption was
noticed among the ﬁve experimental groups. Rats typically drank
∼20 ml of ALCAR solution per day, which would provide a daily dose
of about 0.5 g/kg of body weight. Old animals were all sacriﬁced at
28 months of age.
2.2. Mitoplast preparation
Rats were sacriﬁced, livers were quickly excised and immediately
used for mitoplast preparation according to Greenawalt [34]. Brieﬂy,
after centrifugation at 660 ×g of homogenized liver, mitochondria
were collected from the supernatant at 15,000 ×g and resuspended in
an isotonic buffer containing 70mM sucrose, 220mMmannitol, 2 mM
HEPES, pH 7.4, and 0.5 mg/ml BSA. After treating the mitochondrial
suspension with 6 mg/ml digitonin, mitoplasts were collected from
the supernatant at 10,000 ×g, resuspended in the above-mentioned
buffer, with 15% glycerol and 0.05 mM EDTA and immediately frozen.Protein concentration was determined using the Bio-Rad Protein
Assay reagent (Bio-Rad Laboratories Inc., Hercules, CA, USA).
2.3. Two-dimensional polyacrylamide gel electrophoresis (2-DE)
Mitoplast proteins were solubilized in rehydration buffer contain-
ing 7 M urea, 2 M thiourea, 4% (w/v) CHAPS, 0.5% (v/v) pH 4–7 IPG
buffer (GE Healthcare Life Sciences, Piscataway, NJ, USA) and 100 mM
DTT. The sample was loaded on 18 cm 4–7 pH gradient IPG strips (GE
Healthcare Life Sciences, Piscataway, NJ, USA) by in-gel sample
rehydration; 100 μg of proteins were loaded on analytical gels, and
800 μg of proteins were loaded on preparative gels. The isoelectric
focusing was performed using the Ettan IPGphor 3 system (GE
Healthcare Life Sciences, Piscataway, NJ, USA), for 29 h for a total of
50,000 VhT. The gel strips were then equilibrated twice for 15 min
with gentle shaking in equilibration solution containing 0.12M Tris pH
7.5, 6 M urea, 30% (v/v) glycerol, 2.5% (w/v) SDS; 65 mM DTT was
added in the ﬁrst step and 240 mM iodoacetamide was added in the
second step. The second dimension was carried out using 10%
polyacrylamide gels. Analytical gels were stained with silver [35]
and preparative gels with colloidal Coomassie [36]. Silver-stained gels
were acquired from the Image Scanner (GE Healthcare Life Sciences,
Piscataway, NJ, USA) and analyzed by Image Master 2D v 6.0 software
(GE Healthcare Life Sciences, Piscataway, NJ, USA). Three gels for each
animal were analyzed. The spots were detected andmatched between
different samples. Individual spot volume values were obtained, by
the software, as percentage spot volume calculated by considering the
total volume over all the spots in the gel. This relative measure takes
into account variations due to protein loading and staining.
2.4. Western blotting analysis
Fifty micrograms of mitoplast proteins were separated by 2-DE, as
described above, 10 μg of mitoplast proteins were separated on 12%
SDS-polyacrylamide slab minigels. Proteins were electroblotted onto
PVDF membranes (GE Healthcare Life Sciences, Piscataway, NJ, USA).
After transfer, the membranes containing blotted proteins were
treated with a blocking buffer containing 20 mM Tris, pH 7.5, 150 mM
NaCl, 1% (v/v) Triton X-100 and 5% (w/v) non-fat dry milk for 1 h,
then were incubated with rabbit anti-Peroxiredoxin III polyclonal
antibody (LabFrontiers, Seoul, South Korea), diluted 1:5000 in
blocking buffer or with anti-peroxiredoxin-SO3 polyclonal antibody
(LabFrontiers, Seoul, South Korea) diluted 1:10,000. After four
washes with blocking buffer, membranes were incubated for 1 h
with peroxidase-conjugated goat anti-rabbit antibody (Santa Cruz
Biotechnology, Santa Cruz, CA, USA), diluted 1:5000 in blocking
buffer, and washed again. Blots were visualized by chemilumines-
cence using the ECL Plus Western Blotting Detection Reagents (GE
Healthcare Life Sciences, Piscataway, NJ, USA), according to the
supplier's instructions, and exposed to ECL ﬁlms (GE Healthcare Life
Sciences, Piscataway, NJ, USA). Autoradiographs were acquired from
the Chemi Doc System and analyzed by Quantity One software (Bio-
Rad Laboratories Inc, Hercules, CA, USA). After the exposure the
membranes were stained with Coomassie Blue and acquired from the
Chemi Doc System to estimate for each lane the total protein content
electroblotted on the membrane. The densitometric value of O.D.
units of each band was then related to the total amount of proteins in
the corresponding lane.
2.5. Mass spectrometry analysis
2.5.1. Nano electrospray ionization (ESI) tandem MS
The protein spots were excised from stained gels and subjected to
in-gel trypsin digestion according to Shevchenko et al. [37]. The
recovered peptide mixtures were then separated by using a nanoﬂow
high performance liquid chromatography system (Ultimate/
Table 1
Spot volume values (%) of PrxIII in the liver mitochondria of adult and old rats treated or
not with ALCAR.
Rats Spot 657 Spot 986 Percentage of spot
986 volume with
respect to old rats
Adult 2.53±0.25 – –
Old 2.32±0.27 2.03±0.11 –
Old, 1m ALCAR 2.80±0.28 1.41±0.13⁎ −30%
Old, 2m ALCAR 2.89±0.24 1.22±0.04⁎ −40%
Old, 2m ALCAR, 1m
treatment suspension
2.67±0.26 1.35±0.12⁎ −34%
Spot volume values were obtained as percentage spot volume calculated by considering
the total volume over all the spots in the gel. Volume values are means±SEM derived
from three 2-DE gels for each of the four animals belonging to the same experimental
group.
Old rats were all sacriﬁced at 28 months of age; m=month.
⁎ pb0.05 versus old rat group.
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with a high-capacity ion trap, HCTplus (Bruker-Daltonik, Germany).
Protein identiﬁcation was performed by searching in the National
Center for Biotechnology Information nonredundant database
(NCBInr) by using the Mascot program (http://www.matrixscience.
com). For positive identiﬁcation, the score of the result had to be over
the signiﬁcance threshold (pb0.05).
2.5.2. MALDI-MS
For MALDI-MS, mass measurements were carried out on a Bruker
BIFLEX III™ MALDI-time-of-ﬂight mass spectrometer equipped with
SCOUT™ High Resolution Optics with X-Y multisample probe and
gridless reﬂector. Samples preparation was carried out according to
Wagner et al. [7]. Monoisotopic peptide masses were assigned and
used for database searches.
2.6. Statistical analysis
In two-dimensional gel analysis the results are shown as themean±
SEM of spot volumes. Statistical analysis was carried out using one-way
Analysis of Variance (ANOVA) followed by Tukey's post hoc test using
SPSS Base 11.5 software (SPSS Inc., Chicago, IL); pb0.05 was considered
statistically signiﬁcant.
For MALDI-MS all statistical analyses were performed using
Microsoft excel data analysis program for Student's t-test analysis
and using statistical analysis program for ANOVA with the Scheffe
multiple comparison test; pb0.05 was considered statistically
signiﬁcant.
3. Results
3.1. Analysis of different PrxIII forms in adult and old rat liver
mitochondria by two-dimensional gel electrophoresis, western blot and
mass spectrometry
The presence of different forms of PrxIII in liver mitochondria of
adult (12-month-old) and old (28-month-old) rats was analyzed by
two-dimensional gel electrophoresis since the native and the different
oxidized forms of Prxs have different pI [9]. Mitoplasts were prepared
to reduce extra mitochondrial protein contamination. Mitoplasts were
freshly isolated from the livers of four rats for each group and
immediately frozen. Mitoplast proteins (50 μg) were separated onFig. 1. Two-dimensional analysis of PrxIII spots in adult and old rat liver. Only the
regions of the gels containing PrxIII spots are shown. Left panels: representative
western blots of adult (A) and old (B) rat liver mitoplast proteins separated on 2-DE gels
and probed against PrxIII antibodies. Fifty micrograms of mitoplast proteins were
loaded into the ﬁrst dimension IPG strips. Ten micrograms of mitoplast proteins were
loaded, as a control (ctr), onto the second dimension gels; molecular weight markers
(kDa) were included on the right. Arrows indicate two PrxIII spots. Right panels:
representative silver-stained gels of proteins from adult (C) and old (D) rat liver
mitoplasts. One hundred micrograms of mitoplast proteins were loaded into the IPG
strips; the gels were stained with silver; arrows indicate the basic (657) and the acidic
(986) PrxIII spots.18 cm IPG strips pH 4–7, in the ﬁrst dimension, and on 10%
polyacrylamide gels in the second dimension, electro-transferred on
PVDF membrane and probed against PrxIII antibodies. As representa-
tively reported in Fig. 1 (panels A, B), two spots of PrxIII, an acidic and
a basic form with the same molecular weight, were revealed in adult
and old rat liver samples. However, the acidic spot was very weak in
adult rats, but as intense as the basic spot in old rats. The basic spot
should correspond to the native form of PrxIII, whereas the acidic spot
to one of the oxidized forms of the enzyme [9].
To localize the two spots of PrxIII on the analytical 2-DE gels, we
separated 100 μg of mitoplast proteins of adult and old rats. By
comparison of the images of western blots and silver-stained gels, we
localized, in a region corresponding to MW around 26 kDa, at a pI
value around 5.9 a basic spot indicated as spot 657 and at a pI value
around 5.7 an acidic spot indicated as spot 986 (Fig.1, panels C, D). The
spot 657 was present both in adult and old rats, whereas the spot 986
was absent in adult and present in the old rat mitochondrial
proteome. The gels of adult and old rats were compared with Image
Master 2D Platinum v 6.0 software, three gels for each animal were
analyzed. In Table 1 the spot volumes of the two PrxIII forms in adult
and old rat are reported. The volume of spot 657 did not change with
age.
To conﬁrm, by mass spectrometry, that the spots 657 and 986, on
the two-dimensional silver-stained gels, corresponded to PrxIII we
separated 800 μg of mitoplast proteins on 2-DE gels stained with
Colloidal Coomassie. The excised spots were trypsin-digested and
analyzed by ESI–MS/MS mass spectrometry. We identiﬁed the basic
spot (spot 657) and the acidic spot (spot 986) as PrxIII; the Mascot
score was 152 and 357 and the coverage 11% and 28%, respectively.
3.2. Identiﬁcation of PrxIII cysteine modiﬁcation
In rat PrxIII the cysteine of the catalytic site is Cys109 included in
the tryptic peptide 95–119. In ESI–MS/MS analysis here used for the
identiﬁcation of the acidic and basic spots this peptide was not
observed. This could be expected since the negative charge carried by
the modiﬁed cysteine is known to create problems in ionization and/
or fragmentation, at least in the positive mode of ion acquisition [7].
This was indeed the case and the Cys-containing peptides could not be
observed in positive mode, neither by MALDI-MS nor by ESI–MS.
When in MALDI-MS analysis the spectra were acquired in negative
mode, the peptide containing the Cys109, as shown in Fig. 2, could be
observed. During sample preparation for the second dimension
analysis, iodoacetamide alkylation of cysteines occurs so that all
cysteines present in the sample should be in the form of CAM
(carboxyamidomethyl) Cys except the oxidized Cys. In MALDI spectra
of the basic spot (Fig. 2A), signals at m/z 3031.22 were observed and
assigned to peptide 95–119 containing the CAM Cys109 (2974.50+
Fig. 2. Identiﬁcation of cysteine-containing peptides of PrxIII by MALDI-MS. The spectra were acquired in negative mode. Peaks corresponding to Cys-containing peptides are
indicated with arrows. (A) Spectrum of the basic spot 657. (B) Spectrum of the acidic spot 986.
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signals at m/z 3022.65 were assigned to the same peptide 95–119,
containing the Cys109 with the thiol group oxidized to sulphonic acid
(2974.50+48=3022.50). The mature form of PrxIII contains other
two cysteines in the peptide 120–149 and in the peptide 219–249,
respectively. As expected, the two peptides showed the same m/z in
the acidic and in the basic spots since these CAM Cys were not
modiﬁed in old rats (Figs. 2A, B). MALDI-MS analysis of the basic and
acidic spots, identiﬁed as PrxIII, allows to conclude that the pI shift of
PrxIII spot in old rat liver mitochondria is due to the overoxidation of
the cysteine of the catalytic site to cysteine sulphonic acid.
3.3. Analysis of PrxIII forms in liver mitochondria of ALCAR-treated rats
To estimate whether ALCAR treatment affected the content of the
overoxidized form of PrxIII in old rats, mitoplast proteins from liver of
28-month-old rats treated with ALCAR for 1 month, for 2 months and
for 2 months followed by 1 month of treatment suspension were
analyzed by two-dimensional gel electrophoresis experiments. Pro-
teins (100 μg) were separated on 18 cm IPG strips pH 4–7, in the ﬁrst
dimension, and on 10% polyacrylamide silver-stained gels in the
second dimension. In Fig. 3 representative two-dimensional gels of
mitoplast proteins from old control rats and ALCAR-treated old rats
are reported. The results of treated rats were compared with those of
the control group by Image Master 2D Platinum v 6.0 software, three
gels for each animal were analyzed. In Table 1 the spot volume values
of the two forms of PrxIII in 28-month-old rats treated with ALCAR for
1 month, for 2 months and for 2 months followed by 1 month of
treatment suspension and untreated rats are reported. The spot
volume of the native form of PrxIII (spot 657) did not change in a
signiﬁcant way in the three groups of treated animals with respect to
the untreated old ones, whereas the spot volume of the overoxidizedform of PrxIII (spot 986) decreased signiﬁcantly with the treatment as
reported in Table 1. No signiﬁcant differences were found between the
three ALCAR-treated groups of old rats.
Western blotting experiments on mitoplast proteins probed with
peroxiredoxin-SO3 antibodies were then performed to conﬁrm the
quantitative data obtained by two-dimensional and mass spectro-
metry analysis. Ten micrograms of mitoplast proteins from each
animal of the ﬁve experimental groups were separated on 12%
polyacrylamide gels, electro-transferred on PVDF membrane and
probed with Prx-SO3 antibodies. In Fig. 4A a representative western
blotting of mitoplast proteins from adult rats (lane 1), old control
rats (lane 2) and ALCAR-treated old rats (lanes 3–5) is reported. The
densitometric value of O.D. units of each band was then related to
the total amount of proteins transferred on the membrane in the
corresponding lane. In the histogram of Fig. 4B bars show the
average values obtained for each group of animals referred to the
mean value of the old rat group. As it is shown, the overoxidized
form of PrxIII in adult rats represents about 10% with respect to the
overoxidized PrxIII in the old group. As far as the ALCAR-treated
groups of old rats, the overoxidized PrxIII is signiﬁcantly decreased
of about 35% in all groups and no signiﬁcant differences were found
among them.
4. Discussion
The data here reported reveal, for the ﬁrst time, the presence and
the accumulation in the liver of four groups of 28-month-old rats of an
acidic form of PrxIII inwhich the cysteine of the catalytic site has been
oxidized to sulphonic acid. This acidic form, present in adult rat liver in
a very low amount, corresponds to the irreversibly inactivated
antioxidant enzyme [7]. The overoxidation of Cys109 of PrxIII is
selective, since Cys128 and Cys230 remain in the reduced form. ALCAR
Fig. 3. Two-dimensional gel electrophoresis of PrxIII spots in 28-month-old rats treated
with ALCAR. Only the regions of the gels containing PrxIII spots are shown.
Representative silver-stained two-dimensional gels of liver mitochondrial proteins
from: old rats (A), rats treated with ALCAR for 1 month (B), rats treated with ALCAR for
2 months (C), rats treated with ALCAR for 2 months and analyzed 1 month after
treatment suspension (D). All rats were sacriﬁced at 28 months of age. In the panels,
arrows indicate the 657 basic spots and the 986 acidic spots.
Fig. 4. Quantitative estimate of the overoxidized PrxIII content by western blotting
using Prx-SO3 antibodies. (A) Representative western blotting carried out on liver
mitochondrial proteins. Samples were from: adult rat (lane 1); old rat (lane 2); rat
treated with ALCAR for 1 month (lane 3); rat treated with ALCAR for 2 months (lane 4);
rat treated with ALCAR for 2 months and analyzed 1 month after treatment suspension
(lane 5). The densitometric value of O.D. units of each band was related to the total
amount of proteins transferred on the membrane. (B) The histogram shows the amount
of the overoxidized PrxIII related to the old rat content. Bars, corresponding to the gel
lanes, represent the average±standard error of values obtained from 3 experiments for
each animal belonging to the same experimental group (n=4). ⁎pb0.05 versus old rat
group.
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PrxIII.
The presence of the sulphonic formof PrxIII in livermitochondria of
old rats is probably due to the age-related oxidative stress conditions
already reported in this tissue [12,13,38]. Contrary to the sulphonic
form (Cys-SO3H), the sulphinic PrxIII form (Cys-SO2H) was not found
probably because it can be reduced to cysteine bycytosolic sulﬁredoxin
(Srx) which translocates into mitochondria [39]. Furthermore, since
the reduction of the sulphinic form by Srx is a very slow process [40],
the sulphinic PrxIII form might spontaneously overoxidize to the
sulphonic acid form due to the oxidative environment. However, it has
been reported that in yeast the sulphonic form of the peroxiredoxin
Tsa1p (Tsa1p-SO3H) is not a spontaneous oxidation product of the
sulphinic form, suggesting the existence of an enzymatic system that
facilitates the formation of the sulphonic form [41].
The accumulation of the acidic inactive form of PrxIII in old rat liver
might be due to the decrease of protease activities involved in the
degradation of oxidized proteins. Aggregates of modiﬁed proteins are
typically observed in aging tissues and the age-dependent dysfunction
of the protein quality control system has been reported [42–44].
Among the mitochondrial proteases [45] the ATP-stimulated Lon
protease plays an important role in the removal of oxidized proteins in
the mitochondrial matrix [44]. A decrease of the activity of Lon
protease has been reported in liver of old rats [46]. A reduction of
expression and activity of this enzyme was associated with an
increased level of oxidized proteins in mice skeletal muscle [47].The post-translational changes of the redox state of a key thiol
protein such as PrxIII might be critical for the mitochondrial as well
as for the cellular functions since the global antioxidant defense
system of the cell and, in particular, of mitochondria should be
affected [3]. However, as revealed by this study, the native PrxIII
enzyme is still present in old rat and in the same amount as in the
adult counterpart. This could mean that PrxIII is constitutively
expressed and that its expression is not inﬂuenced by the accumula-
tion of the acidic form of PrxIII. Otherwise, we have to hypothesize
that aged rat liver is able to feel the gap and keep constant its
antioxidant defense level in a situation of chronic ROS production as
that of rat liver during aging [12,13,38]. This last hypothesis seems to
be supported by an increased amount of transcript for the PrxIII gene
found in bovine aortic endothelial cells exposed to oxidative stress as
well as by an increased protein content found in the rat ischemic
myocardium [48].
However, the irreversibly overoxidized inactive PrxIII might not be
an impaired dead-end product destined to be removed as usually
believed. In fact, in mammalian cells, oxidation of mitochondrial
PrxIII, followed only later on by oxidation of PrxI and PrxII, has been
reported during the initiation of the receptor-mediated apoptosis
[5,49]. Furthermore, in the yeast, the irreversibly hyperoxidized
peroxiredoxin (Tsa1p-SO3H), in oxidative stress conditions, functions
as an effective and stable molecular chaperone [41].
The ability of the ALCAR treatment to maintain mitochondrial
homeostasis and/or energy levels in different aged tissues and in
various age-related degenerative conditions [15–26,29] might be
responsible for the partial prevention of overoxidation and/or the
accumulation of oxidized protein here reported. ALCAR, in fact, might
buffer the oxidative stress and prevent the depletion of ATP [17,29].
ALCAR might pursue such goals with the same mechanism suggested
by Guarente for caloric restricted diet, that is by inducing mitochon-
drial biogenesis [50]. In fact, ALCAR feeding during unloading, a
condition that accelerates the negative effect of age on skeletal muscle
[51], triggers in rat soleus muscle the coordinated expression of genes
involved inmitochondrial biogenesis like PCG-1alpha, NRF1 and TFAM
895C. Musicco et al. / Biochimica et Biophysica Acta 1787 (2009) 890–896[23] and increases the mitochondrial mass [23,24]. Two months of
ALCAR treatment prevented in the soleusmuscle of 28-month-old rats
the age-related decrease of TFAM [22] as well as of PGC-1alpha protein
content (Pesce, V., personal communication). PGC-1alpha, a master
regulator of mitochondrial biogenesis [52], controls also the expres-
sion of the enzymes of the mitochondrial antioxidant defense systems
like PrxIII [53] and mitochondrial Lon protease [54]. Therefore ALCAR,
by stimulating the expression of PGC-1alpha might favor mitochon-
drial biogenesis and, in the same time, reduce the overoxidation of
PrxIII and/or induce the degradation of overoxidized PrxIII.
In conclusion, this is the ﬁrst report demonstrating, in a tissue of
old rat, the presence as well as the accumulation of the PrxIII
containing the Cys sulphonic acid in the catalytic site. Furthermore, for
the ﬁrst time, ALCAR involvement in a partial prevention of over-
oxidation and/or accumulation of the overoxidized form of a speciﬁc
mitochondrial enzyme is reported, although with a yet unknown
mechanism.
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